The July Wellness Index Report, published by Wellness Eternal's Biohacking Index, identifies a quiet reversal in how leading practitioners approach longevity. For a century, medicine's instinct was to override biology. A new generation is working with what the body already produces and asking it to do what it was built to do.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways
The July Wellness Index Report finds the most interesting question in longevity is no longer what can be added to the body, but what the body already has and why we stopped listening to it.
The report identifies three signals: midlife hormone health moving into legitimate clinical priority, regeneration replacing repair, and a microbiome category being reshaped by published evidence.
Three companies are featured across three depths of that idea: International Pause Institute, PUR-FORM, and FitBiomics.
The Wellness Index Report applies a four-step verification process built on expert nomination, customer and patient feedback, clinical review, and ongoing performance tracking.
The Signals
Midlife hormone health steps out of the shadows. Perimenopause, menopause and andropause are moving from whispered inconvenience to legitimate clinical priority. Consumers over 40 are rejecting the idea that fatigue, brain fog, weight change and loss of libido are simply the cost of getting older. Demand is climbing for integrative, root-cause care that treats hormones, the microbiome and lifestyle as one connected system.
Regeneration replaces repair. Patients facing joint pain, injury and inflammation are increasingly seeking alternatives to surgery and long-term pharmaceutical management. Interest continues to grow in approaches that use a person's own platelets, growth factors and cells, delivered by physicians and paired with technologies addressing oxygenation, inflammation and cellular stress.
The microbiome grows up. After a decade of broad claims and thin evidence, the category is being reshaped by companies willing to run studies and publish them. Consumers are moving past generic probiotics toward strains with defined origins, specific functions and peer-reviewed clinical validation.
The July Features
International Pause Institute (New Jersey). Founded by Dr. Betsy Greenleaf, DO, the first woman in the United States board certified in Urogynecology, the practice serves both women and men through perimenopause, menopause and andropause. Its integrative, functional approach spans hormone optimization, microbiome health, stress resilience and sexual wellness. Triple board certified with fellowship training in integrative medicine, Greenleaf is a bestselling author, award-winning speaker and founder of Femversity. Her programs, including the Pause Protocol, address the underlying drivers of fatigue, brain fog and lost vitality rather than treating each symptom in isolation.
PUR-FORM (Boca Raton, Florida). Medical Director Dr. Joseph Purita, MD, is a board certified orthopedic surgeon trained at Georgetown, a pioneer of Platelet Rich Plasma and orthopedic regenerative cell treatments, and inaugural president of the American Academy and Board of Regenerative Medicine. He has lectured at more than 200 conferences worldwide. The practice combines regenerative orthopedics and PRP with a technology stack including EBO2 and ozone therapy, hyperbaric oxygen, peptide therapy, NAD+, intermittent hypoxia and contrast therapy, alongside hormone health and medical weight loss. Procedures use patients' own autologous regenerative cells and growth factors, delivered under physician direction.
FitBiomics (New York, New York). Spun out of Harvard's Wyss Institute in 2018 by Dr. Jonathan Scheiman, PhD, a former St. John's basketball player turned biomedicine PhD, FitBiomics decodes the microbiomes of elite athletes and translates them into next generation probiotics. Flagship product Nella uses three proprietary athlete-derived Lactobacillus strains and has been clinically studied for sleep and gut health, with results published in the peer-reviewed journal Microbiome. Companion product V-Nella is built on Veillonella, the lactic acid metabolizing genus first identified in ultramarathon runners. The company was co-founded with Harvard geneticist Dr. George Church.
Commentary
"The future of longevity may depend less on what we invent and more on what we finally learn to work with. Hormones, cells, microbes. The body has been offering the answer for a long time. We are only now building the tools to hear it," said Lindsay O'Neill-O'Keefe, Founder of Wellness Eternal and proprietor of the Wellness Index Report.
"Different scales, one philosophy. Whether it is restoring the hormones of midlife, mobilizing the regenerative capacity already circulating in a patient's own blood, or borrowing the microbial advantages of the fittest people alive, these three practitioners are pointing at the same conclusion," O'Neill-O'Keefe added. "The most powerful pharmacy may be the one we were born with."
